Clinical Trials Directory

Trials / Unknown

UnknownNCT01025011

Non-invasive Measurement of Hemoglobin in Retinal Arteries

Non- Invasive Measurement of the Absolute Hemoglobin Value in the Retinal Arteries of Anemic and Healthy Subjects Using a New Approach

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Triemli Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to test a new non-invasive tool to measure hemoglobin in retinal arteries.

Detailed description

To our knowledge no tool exists that allows for direct collection of hemoglobin data in the eye. In many eye diseases (especially diabetic and hypertensive retinopathy as well as in retinal vessel occlusions) retinal circulation is modified. Knowing hemoglobin concentration on the site of the pathology will give us further information about the pathogenesis of this diseases and may provide a new possibility in therapy. The purpose of this study is to test a new non-invasive tool to measure hemoglobin in retinal arteries. Healthy volunteers from the eye clinic and pregnant otherwise healthy patients of the gynecological department of the Triemli Hospital, Zurich, as well as anemic gynecological patients that show up for a check-up are included. Hemoglobin will be quantified by a blood draw of a cubital vein. Using a Fundus Camera (Nidek AFC-230) pictures of the fundus will be taken from each study patient. Afterwards the study investigator selects a retinal artery of interest which will be used for measuring the hemoglobin concentration. Intensity of the green channel of the camera chip is determined with the aid of the law of Lambert-Beer. Absolute Hemoglobin concentration is calculated in relation to the vessel volume.

Conditions

Interventions

TypeNameDescription
DEVICEFundus photography, cubital blood drawblood draw from a cubital vein to measure hemoglobin concentration taking a fundus photography with a Nidek AFC-230, no pupil dilation needed

Timeline

Start date
2008-03-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2009-12-03
Last updated
2009-12-03

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01025011. Inclusion in this directory is not an endorsement.